W.L. GORE & ASSOCIATES

Manufacturer adverse-event records for W.L. GORE & ASSOCIATES come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.

FDA MAUDE device safety record · 1994–2022 · mid-book · elevated Death-code · injury-heavy

Death-code intensity

W.L. GORE & ASSOCIATES carries an elevated Death-code share

Death-coded event_type rows are 858 of 13,722 (6.25% · elevated tercile among 443 manufacturers). Absolute volume is mid-book.

What the Death-code reading shows for W.L. GORE & ASSOCIATES

The standout signal for W.L. GORE & ASSOCIATES is Death-code intensity: 6.25% of 13,722 reports (elevated tercile), while absolute volume is mid-book.

Mid-pack volume still shows a clear device fingerprint; the table below is the actionable layer for W.L. GORE & ASSOCIATES. Event_type Death/Injury codes differ from patient-outcome rows - see methodology.

Reports span 20 device types, led in this extract by Injury at 11,522 (84.0% of event_type total). Peak single-year volume reaches 2,445 reports across 27 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.

13,722
Total Reports
858
Event-type Death
11,522
Injury Reports
20
Device Types

Event Types

Injury 11,522 (84.0%)
Malfunction 1,318 (9.6%)
Death 858 (6.3%)
Other 14 (0.1%)
10 (0.1%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

Hospitalization 6,930 (31.1%)
R 6,545 (29.4%)
Required Intervention 2,882 (12.9%)
Other 1,842 (8.3%)
O 1,523 (6.8%)
993 (4.5%)
Death 902 (4.0%)
H 196 (0.9%)
L 156 (0.7%)
S 148 (0.7%)
Life Threatening 91 (0.4%)
Disability 80 (0.4%)
Congenital Anomaly 1 (0.0%)

Yearly Trend

94
1994: 1
96
1996: 2
97
1997: 1
98
1998: 2
99
1999: 3
00
2000: 1
01
2001: 1
03
2003: 15
04
2004: 71
05
2005: 63
06
2006: 17
07
2007: 14
08
2008: 287
09
2009: 573
10
2010: 528
11
2011: 653
12
2012: 811
13
2013: 695
14
2014: 947
15
2015: 1,300
16
2016: 1,570
17
2017: 1,301
18
2018: 1,526
19
2019: 2,445
20
2020: 876
21
2021: 8
22
2022: 11